Atlanta Pharmaceutical Research Center

Dunwoody, Georgia 30338

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Type 2, Diabetes, Type 1, Diabetes, Type 2, Diabetes, Type I, Type 1 Diabetes, Type 2 Diabetes

Studies at this site

• A 2-Month Safety Follow-Up Trial — Completed
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes — Completed
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma — Stopped early